Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Change in Taxes (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Change in Taxes for 16 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • Quarterly Change in Taxes fell 200.0% to -$1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.4 million through Dec 2025, down 780.0% year-over-year, with the annual reading at -$4.4 million for FY2025, 780.0% down from the prior year.
  • Change in Taxes for Q4 2025 was -$1.8 million at Myriad Genetics, down from -$500000.0 in the prior quarter.
  • The five-year high for Change in Taxes was $18.1 million in Q4 2021, with the low at -$90.3 million in Q1 2021.
  • Average Change in Taxes over 5 years is -$5.7 million, with a median of -$500000.0 recorded in 2023.
  • Peak annual rise in Change in Taxes hit 102.02% in 2021, while the deepest fall reached 13000.0% in 2021.
  • Over 5 years, Change in Taxes stood at $18.1 million in 2021, then crashed by 101.1% to -$200000.0 in 2022, then crashed by 150.0% to -$500000.0 in 2023, then dropped by 20.0% to -$600000.0 in 2024, then plummeted by 200.0% to -$1.8 million in 2025.
  • According to Business Quant data, Change in Taxes over the past three periods came in at -$1.8 million, -$500000.0, and -$2.1 million for Q4 2025, Q3 2025, and Q1 2025 respectively.